Twist Bioscience Corporation (NASDAQ:TWST) is among the Best ARK Stocks.
On May 4, Twist Bioscience Corporation (NASDAQ:TWST) expanded its clonal genes portfolio with an early access launch of “Complex Genes,” the company said. The firm added support for longer and more structurally complex DNA sequences.
Complex Genes increases maximum gene length to 7,000 base pairs while allowing acceptance of about 99.5% of clonal gene orders and 99.9% of all DNA products, the company said. It targets sequences historically difficult to produce at scale.
Twist Bioscience Corporation (NASDAQ:TWST) CEO Emily Leproust said researchers need partners that “consistently deliver genes rapidly at scale and with more complex sequences.” The CEO added that the expansion allows the firm to accept a broader range of designs and accelerate discovery timelines.
The company said the capability supports AI-powered drug discovery and nucleic acid therapeutics, where precise synthesis of complex sequences remains critical.
Twist Bioscience Corporation (NASDAQ:TWST) is developing a patented semiconductor-based synthetic DNA production technique. It operates in the Americas, EMEA, and APAC.
While we acknowledge the potential of TWST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
